And the results of that trial were published last August (2017): Title: Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial Authors: Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T Journal: Lancet 2017 Aug 3
Studies on leveraging that for weight loss have been mixed
Currently, the company is addressing areas such as cardiovascular risk, metabolic dysfunction and hormone levels, and plans to expand into performance, recovery and sleep, Dudum noted
Interest in taking GLP-1s for weight loss jumps to 43% among adults who have been diagnosed as overweight or obese in the past five years
"The FDA supports development of complex generic drugs, such as GLP-1s, by funding research and informing industry through guidance as part of our ongoing efforts to increase access to needed medications
These methyl groups are crucial for various biological processes like DNA methylation, a key mechanism that controls which of our genes are turned on and off